Canine Platelet-Rich Plasma Systems: A Prospective Analysis

Area of Science:

• Veterinary Medicine
• Biotechnology
• Regenerative Medicine

Background:

• Platelet-rich plasma (PRP) is utilized in veterinary medicine for its regenerative properties.
• Variability exists in the efficacy of commercial PRP systems.
• Quantifying the performance of canine-specific PRP systems is crucial for clinical application.

Purpose of the Study:

• To quantitatively assess key parameters of platelet-rich plasma (PRP) products from five commercial systems in healthy adult canines.
• To compare the performance of different commercial PRP systems in terms of cellular component concentrations.

Main Methods:

• A prospective study involving 10 healthy dogs per commercial PRP system.
• Blood samples were collected and processed according to each manufacturer's protocol.
• Concentrations of platelets, red blood cells (RBCs), white blood cells (WBCs), neutrophils, monocytes, and lymphocytes were measured in whole blood and PRP, with statistical analysis using paired t-tests (p<0.05).

Main Results:

• Platelet concentrations significantly increased with System 1 (p=0.0088) and System 3 (p<0.0001), but decreased with System 2 (p<0.0001).
• All five systems significantly reduced red blood cell (RBC) concentrations (p<0.0001).
• Neutrophil concentrations decreased significantly with Systems 2, 3, and 4 (p<0.0001), but increased with System 5 (p=0.0089).

Conclusions:

• Systems 1 and 3 demonstrated the highest platelet yields.
• System 3 showed a favorable profile by increasing platelet concentration while significantly reducing RBC and neutrophil counts.
• Further research is needed to determine the clinical efficacy and applications of canine PRP therapy and specific systems.